Characterization of Distinct Monocyte Subtypes and Immune Features Associated with HIV, Tuberculosis, and Coronary

José Cobeña-Reyes1, Celestine N Wanjalla2,3,4, Manuel G Feria5

  • 1Division of Biomedical Informatics, Cincinnati; Children's Hospital Medical Center, Cincinnati, Ohio.

Pathogens & Immunity
|February 5, 2026
PubMed

Insights

Coronary artery disease (CAD), tuberculosis (TB), and HIV impact monocytes. Distinct non-classical monocyte subsets are altered in individuals with CAD and HIV/TB, offering insights for targeted therapies.

Area of Science:

  • Immunology
  • Cardiovascular Disease
  • Infectious Disease

Background:

  • Coronary artery disease (CAD), tuberculosis (TB), and HIV are significant global health issues.
  • Monocytes play a key role in chronic inflammation and immune dysregulation associated with these diseases.
  • Understanding monocyte heterogeneity is crucial for elucidating disease mechanisms.

Purpose of the Study:

  • To characterize monocyte heterogeneity in Ugandan adults with co-occurring HIV, TB, and CAD.
  • To identify distinct monocyte phenotypes associated with CAD and TB.
  • To explore the role of monocyte subsets in inflammation and immune responses.

Main Methods:

  • Mass cytometry was used to analyze monocyte heterogeneity in 61 Ugandan adults.
  • An integrated approach combining manual gating, unsupervised clustering, and machine learning was employed.
  • Plasma levels of soluble CD14 (sCD14) and sCD163 were measured, and CAD/TB status was confirmed.

Main Results:

  • Individuals with HIV and TB showed elevated sCD14 plasma levels.
  • CAD was associated with reduced CD163 expression on non-classical monocytes.
  • Two distinct non-classical monocyte subsets were identified: one depleted in CAD, another enriched in latent TB.

Conclusions:

  • Monocyte alterations are complex in CAD, especially in HIV/TB co-endemic regions.
  • Distinct non-classical monocyte subpopulations are associated with CAD and HIV/TB.
  • Findings may inform the development of precision biomarkers and immune-targeted therapies.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
480
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
276
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
385
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
699
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
3.3K